Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines

被引:31
作者
Williams, SV
Sibley, KD
Davies, AM
Nishiyama, H
Hornigold, N
Coulter, J
Kennedy, WJ
Skilleter, A
Habuchi, T
Knowles, MA
机构
[1] St James Univ Hosp, Imperial Canc Res Fund, Ctr Clin, Leeds LS9 7TF, W Yorkshire, England
[2] Akita Univ, Sch Med, Dept Urol, Akita 010, Japan
关键词
D O I
10.1002/gcc.10050
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Underrepresentation of chromosome 9 is a common finding in bladder cancer. Frequent loss of the whole chromosome suggests the presence of at least one relevant tumor suppressor gene on each arm. Candidate regions identified by loss of heterozygosity (LOH) analysis include a region at 9p21 containing CDKN2A, which encodes p16 and p14(ARF), a large region at 9q12-31 including PTCH and many other genes, a small region at 9q32-33, which includes the DBCCR1 gene, and a region at 9q34 including the TSC1 gene. Experimental replacement of genes or chromosomes into tumor cells with appropriate deletions or mutations represents an important approach to test the functional significance of candidate tumor suppressor genes. Loss of an entire copy of chromosome 9 in many bladder tumor cell lines provides no indication of which gene or genes are affected, and selection of appropriate recipient cells for gene replacement is difficult. We have investigated three candidate tumor suppressor genes on chromosome 9 (CDKN2A, DBCCR1, and TSC1), at the DNA level and by expression analysis in a panel of bladder tumor cell lines, many of which have probable LOH along the length of the chromosome, as indicated by homozygosity for multiple polymorphic markers. Cytogenetically, we found no reduction in the numbers of chromosomes 9 relative to total chromosome count. Homozygous deletion of the CDKN2A locus was frequent but homozygous deletion of TSC1 was not found. A new cell line, DSH1, derived from a pT1G2 transitional cell carcinoma with known homozygous deletion of DBCCR1, is described. This study identifies suitable cell lines for future functional analysis of both CDKN2A and DBCCR1. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:86 / 96
页数:11
相关论文
共 50 条
[41]   SPARC: a bladder cancer tumor-suppressor via targeting metabolic programming. [J].
Almousa, Sameh Waleed ;
Ghoneum, Alia ;
Afify, Hesham ;
Said, Neveen .
CANCER RESEARCH, 2021, 81 (13)
[42]   Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer [J].
Fullwood, P ;
Marchini, S ;
Rader, JS ;
Martinez, A ;
Macartney, D ;
Broggini, M ;
Morelli, C ;
Barbanti-Brodano, G ;
Maher, ER ;
Latif, F .
CANCER RESEARCH, 1999, 59 (18) :4662-4667
[44]   NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma [J].
Furuta, Hiroshi ;
Kondo, Yuudai ;
Nakahata, Shingo ;
Hamasaki, Makoto ;
Sakoda, Sumio ;
Morishita, Kazuhiro .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 391 (04) :1785-1791
[45]   Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines [J].
Mao, L ;
Fan, YH ;
Lotan, R ;
Hong, WK .
CANCER RESEARCH, 1996, 56 (22) :5128-5131
[46]   Molecular characterization of a t(9;12)(p21;q13) balanced chromosome translocation in combination with integrative genomics analysis identifies C9orf14 as a candidate tumor-suppressor [J].
Pujana, Miguel Angel ;
Ruiz, Anna ;
Badenas, Celia ;
Puig-Butille, Josep-Anton ;
Nadal, Marga ;
Stark, Mitchell ;
Gomez, Laia ;
Valls, Joan ;
Sole, Xavier ;
Hernandez, Pilar ;
Cerrato, Celia ;
Madrigal, Irene ;
de Cid, Rafael ;
Aguilar, Helena ;
Capella, Gabriel ;
Cal, Santiago ;
James, Michael R. ;
Walker, Graeme J. ;
Malvehy, Josep ;
Mila, Montserrat ;
Hayward, Nicholas K. ;
Estivill, Xavier ;
Puig, Susana .
GENES CHROMOSOMES & CANCER, 2007, 46 (02) :155-162
[47]   Localization of a novel tumor suppressor gene loci on chromosome 9p21-22 in oral cancer [J].
Nakanishi, H ;
Wang, XL ;
Imai, FL ;
Kato, J ;
Shiiba, M ;
Miya, T ;
Imai, Y ;
Tanzawa, H .
ANTICANCER RESEARCH, 1999, 19 (1A) :29-34
[48]   Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis [J].
Jacoby, LB ;
Jones, D ;
Davis, K ;
Kronn, D ;
Short, MP ;
Gusella, J ;
MacCollin, M .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (06) :1293-1302
[49]   INACTIVATION OF TUMOR-SUPPRESSOR GENES AND DEREGULATION OF THE C-MYC GENE IN UROTHELIAL CANCER CELL-LINES [J].
GRIMM, MO ;
JURGENS, B ;
SCHULZ, WA ;
DECKEN, K ;
MAKRI, D ;
SCHMITZDRAGER, BJ .
UROLOGICAL RESEARCH, 1995, 23 (05) :293-300
[50]   GENOME-WIDE SEARCH FOR LOSS OF HETEROZYGOSITY IN TRANSGENIC MOUSE-TUMORS REVEALS CANDIDATE TUMOR-SUPPRESSOR GENES ON CHROMOSOME-9 AND CHROMOSOME-16 [J].
DIETRICH, WF ;
RADANY, EH ;
SMITH, JS ;
BISHOP, JM ;
HANAHAN, D ;
LANDER, ES .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9451-9455